Friday, November 1, 2024

LAST CHANCE TO REGISTER: Join Our Upcoming Workshop: Drug Product Submission (NDS) Preparation in CTD and eCTD Format – Level 1

Greetings!


We are excited to invite you to the Drug Product Submission (NDS) Preparation in CTD and eCTD Format Workshop – Level 1, hosted by AAPS on November 8, 2024, from 2:00 pm to 4:00 pm. (EST)


This online workshop provides a foundational understanding of regulatory affairs in the healthcare industry, with a special emphasis on the drug development process and new drug submissions.

REGISTER TODAY!

This workshop is ideal for individuals new to regulatory affairs or those looking to strengthen their foundational knowledge. It is particularly beneficial for professionals working in pharmaceutical roles such as regulatory affairs specialists, drug development professionals, quality assurance personnel, and anyone involved in the submission and approval process of new drugs. Attendees will walk away with a clearer understanding of the regulatory submission requirements and the drug development process, while also gaining practical insights into the structure and advantages of using the CTD and eCTD formats.

LEARN MORE

Attendees will receive a certificate of attendance upon completing the workshop, enhancing their professional credentials in the pharmaceutical and regulatory sectors. Make sure to register for this essential event before the deadline on November 1, 2024.


Space is limited, and registration is available now through our website or by contacting us directly at info@aaps.ca. We look forward to your participation in this insightful and practical workshop.


For additional details about the event or to explore other workshops offered by AAPS, feel free to contact us.

Date and Time:

Nov 8, 2024

2:00 PM - 4:00 PM (EST)


How is the workshop delivered?

Live. Virtual. Interactive. Instructor-led.

REGISTER TODAY!

Interested in this workshop?

Register today by calling our team at 416-502-2277 or email us at info@aaps.ca.

Facebook  Instagram  LinkedIn  Web  YouTube

No comments:

Post a Comment